Arbutus files patent infringement lawsuits against Pfizer over Covid-19 vaccine

Pennsylvania-based Arbutus alleges Pfizer and BioNTech infringed on five of its patents when making and selling their Covid-19 vaccine. Arbutus filed a similar suit against Cambridge-based Moderna last year.

Deals Day: Dallas real estate equity fund makes third purchase in 6 months

Denver’s housing vacancy rate is among nation’s lowest

Luxury living: These Orlando mansions fetched October’s top prices

Long-serving South African restaurant listed for sale in Buckhead

Exclusive: Cushman & Wakefield announces new leader as Doug Brandon transitions to advisory role

$157M acquisition of Portland cannabis company closes

New Carillon Park exhibit pays homage to billion-dollar Dayton company

Temple Health posts $37.5M quarterly loss; CEO outlines expansion plans

Arbutus files patent infringement lawsuits against Pfizer over Covid-19 vaccine

Previous OP’s DataAppraisal lands $900K preseed round

Next D.C. to put Emergent BioSolutions’ opioid overdose drug Narcan in vending machines

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Brookfield closes deal for Ritz-Carlton, two other Bay Area hotels in multibillion-dollar REIT buy

Providence fintech Marstone unveils financial wellness mapping app

Crow Holdings Development targets Gastonia for next large industrial project in Charlotte region

Houston-based residential firm joins cloud-based brokerage

$158 million agricultural center proposed for Jefferson County

WakeMed, UNC and Johns Hopkins bring worker well-being to the forefront

MENU

FirstStar Group

More Stories

$80M infusion makes Durham’s M&F Bank a ‘bigger player’